Have a feature idea you'd love to see implemented?
Let us know!
TLRY Tilray Inc
Price (delayed)
$1.31
Market cap
$1.18B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.27
Enterprise value
$1.37B
Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal,
Highlights
The EPS has soared by 88% year-on-year and by 18% since the previous quarter
TLRY's net income has soared by 85% YoY and by 13% from the previous quarter
Key stats
What are the main financial stats of TLRY
Market
Valuations
Earnings
Shares outstanding
903.29M
Market cap
$1.18B
Enterprise value
$1.37B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.32
Price to sales (P/S)
1.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.68
Revenue
$812.04M
EBIT
-$209.18M
EBITDA
-$81.24M
Free cash flow
-$74.01M
Per share
Balance sheet
Liquidity
EPS
-$0.27
Free cash flow per share
-$0.08
Book value per share
$4.13
Revenue per share
$0.93
TBVPS
$1.53
Total assets
$4.26B
Total liabilities
$778.45M
Debt
$388.42M
Equity
$3.48B
Working capital
$432.33M
Debt to equity
0.11
Current ratio
2.47
Quick ratio
1.31
Net debt/EBITDA
-2.26
Margins
Efficiency
Dividend
EBITDA margin
-10%
Gross margin
29.4%
Net margin
-26.2%
Operating margin
-22.4%
Return on assets
-5%
Return on equity
-6.2%
Return on invested capital
-16.6%
Return on capital employed
-5.3%
Return on sales
-25.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TLRY stock price
How has the Tilray stock price performed over time
Intraday
1.55%
1 week
-5.07%
1 month
-17.09%
1 year
-26.4%
YTD
-43.04%
QTD
-25.57%
Financial performance
How have Tilray's revenue and profit performed over time
Revenue
$812.04M
Gross profit
$238.86M
Operating income
-$181.64M
Net income
-$212.62M
Gross margin
29.4%
Net margin
-26.2%
The operating margin has soared by 90% YoY and by 7% from the previous quarter
The net margin has soared by 88% YoY and by 16% from the previous quarter
The operating income has surged by 87% year-on-year and by 4.7% since the previous quarter
TLRY's net income has soared by 85% YoY and by 13% from the previous quarter
Growth
What is Tilray's growth rate over time
Valuation
What is Tilray stock price valuation
P/E
N/A
P/B
0.32
P/S
1.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.68
The EPS has soared by 88% year-on-year and by 18% since the previous quarter
The price to book (P/B) is 73% lower than the 5-year quarterly average of 1.2 and 20% lower than the last 4 quarters average of 0.4
TLRY's equity is up by 2.9% year-on-year
TLRY's price to sales (P/S) is 69% less than its 5-year quarterly average of 4.6 and 22% less than its last 4 quarters average of 1.8
TLRY's revenue is up by 25% year-on-year and by 2.9% since the previous quarter
Efficiency
How efficient is Tilray business performance
The ROS has soared by 88% year-on-year and by 13% since the previous quarter
The company's return on equity has surged by 84% YoY and by 14% QoQ
The company's return on assets has surged by 84% YoY and by 12% QoQ
The ROIC has soared by 84% YoY and by 11% from the previous quarter
Dividends
What is TLRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TLRY.
Financial health
How did Tilray financials performed over time
Tilray's current ratio has surged by 60% YoY and by 9% QoQ
Tilray's quick ratio has increased by 28% YoY and by 8% from the previous quarter
The debt is 89% less than the equity
Tilray's debt to equity has decreased by 35% YoY
The debt has contracted by 31% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.